SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905718-17-000535
Filing Date
2017-05-08
Accepted
2017-05-08 16:33:41
Documents
1
Group Members
ABINGWORTH BIOVENTURES VI, LP

Document Format Files

Seq Description Document Type Size
1 VERONA PHARMA PLC SC 13D veronapharm13dapr272017.htm SC 13D 96171
  Complete submission text file 0000905718-17-000535.txt   97639
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Subject) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89843 | Film No.: 17822913
SIC: 2834 Pharmaceutical Preparations